Colombia need a modern national epidemiological surveillance system and to enlarge the use of molecular diagnosis in infectious diseases;Sobre la necesidad de modernizar la vigilancia epidemiológica y de ampliar el uso del diagnóstico molecular para las enfermedades infecciosas en Colombia

Infectio

Volumn 18, Issue 3, 2014, Pages 77-78

  Gómez Marín, Jorge Enrique ^a,b  

^a UNIVERSIDAD DEL QUINDÍO   (Colombia)

^b Asociación Colombiana de Infectología ^*  (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

COLOMBIA; DISEASE SURVEILLANCE; EDITORIAL; INFECTION; MOLECULAR DIAGNOSIS;

EID: 84943367110     PISSN: 01239392     EISSN: 24223794     Source Type: Journal    
DOI: 10.1002/14651858.CD009593.pub2     Document Type: Editorial

References (7)

1. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430(6996):242-9.
2. Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One. 2009;4(3):e5079.
3. He Q, Barkoff AM, Mertsola J, Glismann S, Bacci S. European Bordetella expert group (EUpertstrain); European surveillance network for vaccine-preventable diseases (EUVAC.NET). High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: Integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill. 2012;17(32).
4. Lai JY, Cook H, Yip TW, Berthelsen J, Gourley S, Krause V, et al. Surveillance of pneumococcal serotype 1 carriage during an outbreak of serotype 1 invasive pneumococcal disease in central Australia 2010-2012. BMC Infect Dis. 2013;13(1): 409.
5. Coronado-Rios S, Arenas-Suarez N, Gomez-Marin JE. Diagnosis of pulmonary and extrapulmonary tuberculosis using an in-house PCR method in clinical samples from a middle-income resource setting. Infectio. 2011;15:145-6.
6. Scott L, Albert H, Gilpin C, Alexander H, Degruy K, Stevens W. A multi-centre feasibility study to assess external quality assessment panels for Xpert(R) MTB/RIF assay in South Africa. J Clin Microbiol. 2014;52:2493-9.
7. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. 2013. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 1:CD009593 [consultado 12 Jun 2014]. Disponible en: http://dx.doi.org/10.1002/14651858.CD009593.pub2